CXCR3 Axis: Role in Inflammatory Bowel Disease and its Therapeutic Implication

Publisher： Bentham Science Publishers

E-ISSN： 2212-3873|7|2|111-123

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.7, Iss.2, 2007-06, pp. : 111-123

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thiopurines in Inflammatory Bowel Disease - The Role of Pharmacogenetics and Therapeutic Drug Monitoring

By  

Current Pharmacogenomics, Vol. 4, Iss. 4, 2006-12 ,pp. : 285-300

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Genetics in Inflammatory Bowel Disease

By  

Current Drug Targets, Vol. 9, Iss. 5, 2008-05 ,pp. : 361-368

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanisms by which Stress Affects the Experimental and Clinical Inflammatory Bowel Disease (IBD): Role of Brain-Gut Axis

By  

Current Neuropharmacology, Vol. 14, Iss. 8, 2016-11 ,pp. : 892-900

Bentham Science Publishers

Access to resources Recommend Favorite

Chemokines and their Receptors as Therapeutic Targets: The Role of the SDF-1 / CXCR4 Axis

By  

Current Pharmaceutical Design, Vol. 10, Iss. 11, 2004-04 ,pp. : 1245-1259

Bentham Science Publishers

Access to resources Recommend Favorite

Current Therapeutic Approaches in Inflammatory Bowel Disease

By  

Current Pharmaceutical Design, Vol. 16, Iss. 33, 2010-11 ,pp. : 3668-3683

Bentham Science Publishers

Access to resources Recommend Favorite